A study on confidential unit exclusion at Shiraz Blood Transfusion Center, Iran
- PMID: 27605850
- PMCID: PMC4993082
- DOI: 10.4103/0973-6247.187939
A study on confidential unit exclusion at Shiraz Blood Transfusion Center, Iran
Abstract
Background: Confidential unit exclusion (CUE) system has been designed to enhance transfusion safety as an extra additive approach.
Aims: This study was designed to survey demographic characteristics, prevalence of serologic markers, and reasons of opting CUE.
Materials and methods: The cross-sectional study was performed at Shiraz Blood Transfusion Center (Southern Iran). CUE is used for all individuals who refer for blood donation, and donors can choose their blood not to be used if they have any doubt about their blood suitability for transfusion. The prevalence rate of HIV, hepatitis B virus (HBV), and hepatitis C virus (HCV) was compared between the blood donors who opted into and out of CUE. Then, the donors were contacted to give another blood sample and the reasons of deferral. Researchers also determined whether their reasons were logical or not. Data were analyzed using comparison of proportions in MedCalc software 7.
Results: Out of all the donors, 2365 ones (2.3%) opted for CUE. CUE was more frequent among men, singles, donors with low education levels, between 18 and 25 years old, and with history of previous donation (P < 0.05). The prevalence rate of HCV was higher among the donors who opted for CUE (P < 0.05), but it was not the case regarding HBV and HIV (P>0.05). Furthermore, 91.5% of the donors had opted for CUE by mistake and only 8% had chosen CUE logically.
Conclusion: It is necessary to review the process of CUE, make some changes both in procedure and design, and then survey its effectiveness in blood safety.
Keywords: Blood-borne transmitted infections; blood donor; blood safety; donor exclusion; donor screening; donor selection.
Similar articles
-
Efficacy of the confidential unit exclusion option in blood donors in tehran, iran, determined by using the nucleic Acid testing method in 2008 and 2009.Hepat Mon. 2011 Nov;11(11):907-12. doi: 10.5812/kowsar.1735143X.778. Epub 2011 Nov 30. Hepat Mon. 2011. PMID: 22308155 Free PMC article.
-
Confidential unit exclusion (CUE): Double edged sword for blood transfusion center: A ten-year study on volunteer blood donors in Kohgiluyeh and Boyer Ahmad province, Iran.Transfus Clin Biol. 2019 Nov;26(4):253-256. doi: 10.1016/j.tracli.2019.05.002. Epub 2019 May 11. Transfus Clin Biol. 2019. PMID: 31174915
-
Comparison of the prevalence of major transfusion-transmitted infections among Iranian blood donors using confidential unit exclusion in an Iranian population: Transfusion-transmitted infections among Iranian blood donors.Hepat Mon. 2011 Jan;11(1):11-3. Hepat Mon. 2011. PMID: 22087109 Free PMC article.
-
[Single-donor (apheresis) platelets and pooled whole-blood-derived platelets--significance and assessment of both blood products].Clin Lab. 2014;60(4):S1-39. doi: 10.7754/clin.lab.2014.140210. Clin Lab. 2014. PMID: 24779310 Review. German.
-
Overview: diagnostic tests for viral infections transmitted by blood.Nucl Med Biol. 1994 Apr;21(3):407-17. doi: 10.1016/0969-8051(94)90064-7. Nucl Med Biol. 1994. PMID: 9234305 Review.
Cited by
-
Subjective donor deferral as a tool for increased blood transfusion safety: A cross-sectional observational study.Health Sci Rep. 2021 Oct 14;4(4):e424. doi: 10.1002/hsr2.424. eCollection 2021 Dec. Health Sci Rep. 2021. PMID: 34693031 Free PMC article.
-
Evaluation of the confidential unit exclusion on Iranian blood donors: An 11-year experience.Asian J Transfus Sci. 2021 Jan-Jun;15(1):57-61. doi: 10.4103/ajts.AJTS_152_18. Epub 2021 Jun 12. Asian J Transfus Sci. 2021. PMID: 34349458 Free PMC article.
References
-
- Newman B. Blood donor suitability and allogeneic whole blood donation. Transfus Med Rev. 2001;15:234–44. - PubMed
-
- Zou S, Musavi F, Notari EP, 4th, Fujii KE, Dodd RY. ARCNET Study Group. Prevalence of selected viral infections among temporarily deferred donors who returned to donate blood: American Red Cross blood donor study. Transfusion. 2005;45:1593–600. - PubMed
-
- Cable R, Musavi F, Notari E, Zou S. ARCNET Research Group. Limited effectiveness of donor deferral registries for transfusion-transmitted disease markers. Transfusion. 2008;48:34–42. - PubMed
-
- Zou S, Musavi F, Notari EP, Rios JA, Trouern-Trend J, Fang CT. Donor deferral and resulting donor loss at the American Red Cross Blood Services, 2001 through 2006. Transfusion. 2008;48:2531–9. - PubMed
LinkOut - more resources
Full Text Sources
Other Literature Sources